Explore the latest developments concerning Oscar Health: The.
Oscar Health: The “insurance disruptor” analysts say could 5X
Shares of Oscar Health (OSCR) have surged 50% over the past six months, but its rally could be just getting started as the company works to disrupt the traditional health insurance industry by improving patient outcomes.
That’s one of the key takeaways from a recent note by Ray Myers, an analyst and author of the Global Equity Briefing investment blog.
Myers described Oscar as a “health insurance disruptor” with the potential to increase its share price fivefold in the foreseeable future, thanks to its differentiated approach compared to traditional insurers.
“Traditional insurers largely act as claims processors. They set up clinical networks, negotiate rates with hospitals, and then pay providers for services rendered,” Myers wrote. “They have very little direct control or influence over how care is delivered or whether it’s truly necessary.”
Oscar Health (OSCR) Stock Rebounds After Sharp Opening Sell-Off, But Analyst Targets Urge Caution
New York, NY – Shares of the health insurance company Oscar Health, Inc. (OSCR) are experiencing significant volatility in today’s trading. As of 10:48 AM EDT, the stock is trading at 0.87, or 4.26%.
The trading session began with a dramatic spike, as the stock surged to a high of $21.80 immediately at the opening bell. However, this peak was short-lived, as the price then plunged sharply to a day’s low of $20.66. Since hitting that bottom, the stock has mounted an impressive V-shaped recovery, demonstrating resilience and attracting dip-buyers. This tug-of-war between buyers and sellers highlights the market’s uncertainty about the stock’s next move.
Fosi Audio Stereo Power Amplifier 300W x2 TPA3255 Class D Mini Speaker Amp 2 Channel Audio Amplifier for Passive Bookshelf
Oscar Health (NYSE:OSCR) Shares Up 10.9% – Still a Buy?
Shares of Oscar Health, Inc. (NYSE:OSCR – Get Free Report) were up 10.9% during mid-day trading on Thursday . The company traded as high as $20.99 and last traded at $21.28. Approximately 4,535,521 shares were traded during mid-day trading, a decline of 20% from the average daily volume of 5,649,624 shares. The stock had previously closed at $19.19.
A number of equities research analysts have issued reports on OSCR shares. Wells Fargo & Company lowered Oscar Health from an "overweight" rating to an "equal weight" rating and cut their price target for the stock from $20.00 to $16.00 in a research note on Thursday, March 13th. Piper Sandler cut their price target on Oscar Health from $25.00 to $18.00 and set an "overweight" rating for the company in a research note on Monday, June 9th. Wall Street Zen lowered Oscar Health from a "buy" rating to a "hold" rating in a research note on Sunday, June 8th. Finally, Raymond James Financial lowered Oscar Health from an "outperform" rating to a "market perform" rating in a research note on Tuesday, June 24th. Two analysts have rated the stock with a sell rating, four have assigned a hold rating and one has issued a buy rating to the company. According to MarketBeat.com, the stock has an average rating of "Hold" and an average target price of $16.50.
For more detailed information and comprehensive insights, explore recent updates concerning Oscar Health: The.
For more news, visit: For more news…